Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.60 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.56 |
| ▸ | RAD52 | P43351 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9161772 | 0.97 | TSHR (0.69) | TSHRALDH1A1NAAAATMEPHX1 | |
| SCHEMBL1981094 | 0.97 | TSHR (0.69) | TSHRALDH1A1NAAAATMEPHX1 | |
| SCHEMBL456055 | 0.97 | TSHR (0.68) | TSHRALDH1A1NAAAATMEPHX1 | |
| SCHEMBL457867 | 0.95 | TSHR (0.72) | TSHRALDH1A1NAAAEPHX1RAD52 | |
| SCHEMBL9955198 | 0.95 | TSHR (0.72) | TSHRALDH1A1NAAAEPHX1RAD52 | |
| SCHEMBL6834546 | 0.95 | TSHR (0.72) | TSHRALDH1A1NAAAEPHX1RAD52 | |
| SCHEMBL2454309 | 0.95 | TSHR (0.72) | TSHRALDH1A1NAAAEPHX1RAD52 | |
| SCHEMBL9955169 | 0.95 | TSHR (0.72) | TSHRALDH1A1NAAAEPHX1RAD52 | |
| SCHEMBL2456606 | 0.95 | TSHR (0.72) | TSHRALDH1A1NAAAEPHX1RAD52 | |
| SCHEMBL15987888 | 0.95 | TSHR (0.72) | TSHRALDH1A1NAAAEPHX1RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113993826-B | Interlayer film for laminated glass, roll, and laminated glass | 积水化学工业株式会社 | 2023-09-19 | — | — | CN | disclosed |
| CN-111655647-B | Interlayer for laminated glass and laminated glass | 积水化学工业株式会社 | 2023-06-20 | — | — | CN | disclosed |
| CN-111655648-B | Interlayer for laminated glass and laminated glass | 积水化学工业株式会社 | 2023-06-02 | — | — | CN | disclosed |
| CN-111918853-B | Interlayer film for laminated glass, and method for manufacturing flat panel display system | 积水化学工业株式会社 | 2023-04-18 | — | — | CN | disclosed |
| CN-111655649-B | Interlayer film for laminated glass, roll body, and laminated glass | 积水化学工业株式会社 | 2023-02-17 | — | — | CN | disclosed |
| CN-115648751-A | Interlayer film for laminated glass and laminated glass | 积水化学工业株式会社 | 2023-01-31 | — | — | CN | disclosed |
| CN-111655650-B | Interlayer film for laminated glass and laminated glass | 积水化学工业株式会社 | 2022-11-18 | — | — | CN | disclosed |
| CN-111683911-B | Intermediate film for laminated glass, roll, and laminated glass | 积水化学工业株式会社 | 2022-11-08 | — | — | CN | disclosed |
| CN-113993826-A | Intermediate film for laminated glass, roll, and laminated glass | 积水化学工业株式会社 | 2022-01-28 | — | — | CN | disclosed |
| CN-111918852-A | Laminated glass, head-up display system, and method for manufacturing head-up display system | 积水化学工业株式会社 | 2020-11-10 | — | — | CN | disclosed |
| CN-111655648-A | Interlayer film for laminated glass and laminated glass | 积水化学工业株式会社 | 2020-09-11 | — | — | CN | disclosed |
| CN-111655650-A | Interlayer film for laminated glass and laminated glass | 积水化学工业株式会社 | 2020-09-11 | — | — | CN | disclosed |
| CN-111655647-A | Interlayer film for laminated glass and laminated glass | 积水化学工业株式会社 | 2020-09-11 | — | — | CN | disclosed |
| US-9545104-B2 | Liquid suspension concentrate formulations containing saflufenacil and glyphosate | BASF SE (DE) | 2017-01-17 | — | — | US | disclosed |
| US-8703650-B2 | Liquid suspension concentrate formulations containing saflufenacil | BASF SE (DE) | 2014-04-22 | — | — | US | disclosed |
| US-20120302444-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL | BASF SE (DE) | 2012-11-29 | — | — | US | disclosed |
| EP-2509422-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL AND GLYPHOSATE | BASF SE (DE) | 2012-10-17 | — | — | EP | disclosed |
| US-20120231954-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL AND GLYPHOSATE | BASF SE (DE) | 2012-09-13 | — | — | US | disclosed |
| WO-2011070054-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL AND GLYPHOSATE | BASF SE (DE) | 2011-06-16 | — | — | WO | disclosed |
| WO-2011070051-A2 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL | BASF SE (DE) | 2011-06-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120302444-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL | SCD5, FFAR3, FFAR2 | TSHR 2738/4885ALDH1A1 977/4885NAAA 1837/4885 |
| US-20120231954-A1 | LIQUID SUSPENSION CONCENTRATE FORMULATIONS CONTAINING SAFLUFENACIL AND GLYPHOSATE | PFAS, SLC6A5, AGXT | TSHR 3264/4885ALDH1A1 2026/4885NAAA 1545/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.